These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35318573)

  • 1. Preferences for Long-Acting and Alternative Modalities for PrEP among Military Men Who Have Sex with Men: Segmentation Results of an Adaptive Choice-Based Conjoint Analysis Study.
    Gutierrez JI; Vlahov D; Dubov A; Altice FL
    J Urban Health; 2022 Apr; 99(2):277-292. PubMed ID: 35318573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences for pre-exposure prophylaxis among U.S. military men who have sex with men: results of an adaptive choice based conjoint analysis study.
    Gutierrez JI; Dubov A; Altice FL; Vlahov D
    Mil Med Res; 2021 May; 8(1):32. PubMed ID: 34006328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.
    Dubov A; Ogunbajo A; Altice FL; Fraenkel L
    AIDS Care; 2019 May; 31(5):545-553. PubMed ID: 30554519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine.
    Dubov A; Fraenkel L; Yorick R; Ogunbajo A; Altice FL
    AIDS Behav; 2018 Apr; 22(4):1100-1112. PubMed ID: 29214409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM; Atujuna M; Browne EN; Ndwayana S; Hartmann M; Sindelo S; Ngcwayi N; Boeri M; Mansfield C; Bekker LG; Montgomery ET
    J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-exposure prophylaxis service among men who have sex with men in Malaysia: findings from a discrete choice experiment.
    Dubov A; Altice FL; Gutierrez JI; Wickersham JA; Azwa I; Kamarulzaman A; Gautam K; Shrestha R
    Sci Rep; 2023 Aug; 13(1):14200. PubMed ID: 37648731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
    Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
    J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis.
    Beckham SW; Sanchez T; Fowler R; Zlotorzynska M; Rai M; Sullivan P; Vannappagari V; Sarkar S; Glick JL; Rinehart AR; Rawlings K; Bridges JFP
    AIDS Patient Care STDS; 2023 Oct; 37(10):495-503. PubMed ID: 37862078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia.
    Chan C; Vaccher S; Fraser D; Grulich AE; Holt M; Zablotska-Manos I; Prestage GP; Bavinton BR
    AIDS Behav; 2022 Jan; 26(1):88-95. PubMed ID: 34142274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.
    Dean LT; Predmore Z; Skinner A; Napoleon S; Chan PA; Raifman J
    AIDS Behav; 2023 Aug; 27(8):2606-2616. PubMed ID: 36670210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice Study.
    Tagliaferri Rael C; Giguere R; Sutton S; Horn E; Schieffer RJ; Greene GJ; D'Aquila R; Bryndza Tfaily E; Kiser PF; Hope TJ
    AIDS Res Hum Retroviruses; 2022 Dec; 38(12):898-908. PubMed ID: 36178358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
    Fu J; Dai Z; Wang H; Si M; Chen X; Wu Y; Xiao W; Huang Y; Yu F; Mi G; Su X
    PLoS One; 2023; 18(10):e0293297. PubMed ID: 37856527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences for long-acting pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey.
    Hsu JH; Ku SW; Chen TW; Li CW; Huang P; Wu HJ; Bourne A; Strong C
    J Int AIDS Soc; 2023 Sep; 26(9):e26163. PubMed ID: 37675767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men.
    Tran NK; Martinez O; Scheim AI; Goldstein ND; Welles SL
    AIDS Educ Prev; 2022 Oct; 34(5):365-378. PubMed ID: 36181495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
    Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
    AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
    Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
    BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa.
    Ogunbajo A; Tsai AC; Kanki PJ; Mayer KH
    AIDS Behav; 2022 Jul; 26(7):2363-2375. PubMed ID: 35061117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
    John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
    Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
    Reyniers T; Fiorentino M; Babo SAY; Ouedraogo M; Kanta I; Agbegnigan LE; Rojas D; Anoma C; Dah TTE; Mensah E; Keita BD; Spire B; Vuylsteke B; Laurent C
    AIDS Patient Care STDS; 2023 Oct; 37(10):480-488. PubMed ID: 37862074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.